Fast new swab test could speed up vaginitis diagnosis
NCT ID NCT07607470
First seen May 26, 2026 · Last updated Jun 23, 2026 · Updated 4 times
Summary
This study will test a new diagnostic device called the Nanopath assay, which aims to quickly detect bacteria or yeast causing vaginitis. Up to 1000 women with symptoms like itching or discharge will provide vaginal swab samples, either collected by a clinician or themselves. The goal is to see how well the new test compares to existing FDA-cleared tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEMALE UROGENITAL DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
LSU-CrescentCare Sexual Health Center
New Orleans, Louisiana, 70119, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nanopath Vaginitis Assay (diagnostic test)
What this could lead to
If successful, this could provide a faster, simpler test for diagnosing vaginal infections, potentially improving treatment decisions.
What could go wrong
This is an early pilot study focused on algorithm development, not a treatment trial. The test may not prove accurate enough or may not be adopted in practice.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.